BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2324735)

  • 1. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates.
    Kuczenski R; Segal DS; Manley LD
    J Neurochem; 1990 May; 54(5):1492-9. PubMed ID: 2324735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats.
    Geyer MA; Russo PV; Segal DS; Kuczenski R
    Pharmacol Biochem Behav; 1987 Nov; 28(3):393-9. PubMed ID: 3685075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioral responses to amphetamine and apomorphine.
    Fink JS; Smith GP
    Brain Res; 1980 Nov; 201(1):107-27. PubMed ID: 7191345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
    de Bruin NM; van Luijtelaar EL; Cools AR; Ellenbroek BA
    Behav Pharmacol; 2001 Nov; 12(6-7):517-25. PubMed ID: 11742146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo measures of monoamines during amphetamine-induced behaviors in rats.
    Kuczenski R; Segal DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S37-50. PubMed ID: 2097672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    VĂ©csei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
    Cools AR; Scheenen W; Eilam D; Golani I
    Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-dopamine interactions. II. Cyclo (His-Pro) augmentation of amphetamine- but not apomorphine-induced stereotypic behavior.
    Prasad C
    Behav Brain Res; 1988 Mar; 27(3):241-5. PubMed ID: 3358861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of single and long-term amphetamine and apomorphine administrations on locomotor activity of rats.
    Bernardi MM; Scavone C; Frussa-Filho R
    Gen Pharmacol; 1986; 17(4):465-8. PubMed ID: 3758653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats.
    Savageau MM; Beatty WW
    Pharmacol Biochem Behav; 1981 Jan; 14(1):17-21. PubMed ID: 7193328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.
    Dickinson SL; Gadie B; Tulloch IF
    Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous hyperprolactinaemia enhances amphetamine- and apomorphine-induced stereotypy.
    Drago F; Van Ree JM; Bohus B; de Wied D
    Eur J Pharmacol; 1981 Jun; 72(2-3):249-53. PubMed ID: 7195817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.